BerandaBCRX • NASDAQ
add
BioCryst Pharmaceuticals Inc
Tutup sebelumnya
$7,04
Rentang hari
$6,15 - $6,98
Rentang tahun
$6,02 - $11,31
Kapitalisasi pasar
1,30Â M USD
Volume Rata-Rata
3,08Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 163,35Â jt | 49,41% |
Biaya operasional | 87,38Â jt | 42,67% |
Laba bersih | 5,08Â jt | 140,12% |
Margin laba bersih | 3,11 | 126,83% |
Penghasilan per saham | 0,04 | 163,33% |
EBITDA | 30,12Â jt | 231,63% |
Tarif pajak efektif | 21,60% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 260,04Â jt | -4,41% |
Total aset | 457,19Â jt | -3,22% |
Total liabilitas | 878,78Â jt | -7,30% |
Total ekuitas | -421,59 jt | — |
Saham yang beredar | 209,92 jt | — |
Harga terhadap nilai buku | -3,50 | — |
Tingkat pengembalian aset | 15,89% | — |
Tingkat pengembalian modal | 21,44% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 5,08Â jt | 140,12% |
Kas dari operasi | 41,30Â jt | 3.119,15% |
Kas dari investasi | 29,13Â jt | 1.289,34% |
Kas dari pembiayaan | -73,69Â jt | -3.648,02% |
Perubahan kas bersih | -16,96Â jt | -186,13% |
Arus kas bebas | 39,77Â jt | 38,59% |
Tentang
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Didirikan
1986
Kantor pusat
Situs
Karyawan
580
